Menü Logo

Intermediate and long-term outcomes following uterine artery fibroid embolization.

Eur J Obstet Gynecol Reprod Biol. 2015 Aug;191:33-8. doi: 10.1016/j.ejogrb.2015.05.016. Epub 2015 May 30.

Hamoda H, Pepas L, Tasker F, Reidy J, Khalaf Y.
King’s College Hospital, London, UK. Electronic address:’s and St Thomas’ Hospital, London, UK.
Eur J Obstet Gynecol Reprod Biol
AbstractOBJECTIVE: To assess patients’ satisfaction and the intermediate and long-term patterns of symptom progression following uterine artery fibroid embolization (UAE).STUDY DESIGN: Intermediate (2-6 years) and long-term (9-14 years) follow-up questionnaire survey to women who underwent UAE during the period 1996-2000, at a tertiary referral centre.RESULTS: The mean (SD) age of women at the time of embolization was 43 (5.58) years. A total of 142/197 (72.1%) women had the embolization in view of heavy menstrual periods, while 87/197 (44%) indicated a desire to retain fertility. 160/197 (81.7%) women who completed Q1 reported an improvement in menstrual symptoms compared to 41/80 (51.2%) for Q2 [p<0.01]. The majority indicated they would recommend the procedure to a friend (Q1: 165 (83.8%), Q2: 62/80 (77.5%)) [p=0.75]. 23/80 (28.8%) required further surgical treatment following UAE, and within the latter group, only 7/23 (30.4%) were satisfied with the embolization. 22/80 (27.5%) tried for a pregnancy following the procedure, and of these 3/22 (13.6%) had a live birth. The mean (SD) age at the menopause for women who returned Q2 was 49.1 (4.91) years.CONCLUSIONS: The majority of women were satisfied with the embolization and noted an improvement in menstrual symptoms. However, this improvement diminished over time following the embolization, and over a quarter of women required further surgical intervention. Findings from this study may provide useful information in counselling women undergoing UAE and help guide clinicians in their patient selection criteria when discussing the procedure.Copyright © 2015 Elsevier Ireland Ltd. All rights reserved.
Full Text Source: Elsevier Science
PMID:26070125 |

Um den vollständigen Inhalt zu sehen, müssen Sie sich einloggen oder sich auf registrieren.

Jetzt einloggen

Passwort vergessen

Jetzt kostenlos registrieren

Mit einer Anmeldung bei haben Sie Zugriff auf: DFP-Kurse, Arzneimittelinfos, Produktfortbildungen und mehr.

Loggen Sie sich ein oder registrieren Sie Ihren kostenlosen Account.